NCT06201494

Brief Summary

Bronchial asthma may present with symptoms other than the commonly reported complaints (cough, chest tightness, shortness of breath and wheezing). Less common symptoms include chronic or recurrent productive cough, inspiratory dyspnoea or recurrent pneumonia. Children presenting with these symptoms are often diagnosed with asthma bronchiale and benefit from antiasthmatic management.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jan 2023Jun 2026

Study Start

First participant enrolled

January 1, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

June 18, 2024

Status Verified

June 1, 2024

Enrollment Period

2.9 years

First QC Date

December 30, 2023

Last Update Submit

June 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of typical and atypical asthma symptoms in children with asthma bronchiale

    We study prevalence of asthma symptoms in children with newly diagnosed asthma. We monitor atypical and atypical symptoms. Typical symptoms are cough, chest tightness, shortness of breath and wheezing according to current global asthma guidelines (GINA). Atypical symptoms are not yet fully documented in literature but they might be represented by recurrent pneumonia, isolated chronic wet cough or inspiratory dyspnoea. Comparison of sensitivity of ISAAC questionaire in group of children with typical and atypical asthma symptoms. In practice, however, it is also possible to see children whose asthma initially manifests as conditions assessed as recurrent pneumonia, isolated chronic cough of a moist nature or as inspiratory dyspnoea. These atypical symptoms are not oficially counted as asthma symptoms. In our study, we focus on prevalence of typical and atypical asthma symtpoms. We study sensitivity of questionaire ISAAC in children with typical and atypical asthma symptoms.

    Initial checkup with asthma symptom documentation and answering the ISAAC questionaire. Suspection on asthma diagnosis and initiation of therapy and scheduled follow-up within 3 months to confirm the diagnosis.

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with suspected diagnosis of asthma without any further chronic disease associated with respiratory symptoms.

You may qualify if:

  • \- Child 3 - 18 years old, first evaluation in pulmonary outpatient clinic for any of the following respiratory symptoms: cough, shortness of breath, chest tightness, wheezing, recurrent lower respiratory tract and lung infections, dyspnoea of any type, pathological listening findings.

You may not qualify if:

  • Other documented chronic respiratory, cardiovascular, neurological, genetic, infectious, metabolic disease, significant immaturity or other disease that may be accompanied by respiratory symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First faculty of Medicine, Charles university.

Prague, 128 00, Czechia

RECRUITING

MeSH Terms

Conditions

AsthmaDyspneaCoughPneumoniaRespiratory SoundsRespiratory Tract Infections

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsInfections

Study Officials

  • Jana Tukova, MD,PhD

    Charles University, Czech Republic First Faculty of Medicine, Prague

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MUDr, Phd

Study Record Dates

First Submitted

December 30, 2023

First Posted

January 11, 2024

Study Start

January 1, 2023

Primary Completion

December 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

June 18, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After completion of study and its publication. For 5 years.
Access Criteria
Proposals should be submitted to jana.tukova@vfn.cz.

Locations